AID Genomics
Early Detection and Personalized Treatment of Cancer and Infectious Diseases
StartupAID Genomics is a Rehovot-based startup in the Health Tech & Life Sciences sector, established in 2018. Early Detection and Personalized Treatment of Cancer and Infectious Diseases . The company has 51-200 employees. Core technologies: Biologicals, Genes, Artificial Intelligence.
The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StagePre-Funding
- ProductReleased
- ModelB2B
- Employees51-200
- HQRehovot
- DistrictCenter District
- Last RoundUndisclosed
9 articles covered by sources including www.calcalist.co.il,
www.ynet.co.il,
bloomer.co.il,
www.jpost.com,
www.globes.co.il.
What does AID Genomics do?
AID Genomics is a research and development-driven diagnostic company focused on the development of precision medicine-based diagnostic solutions primarily for oncology, hereditary rare diseases, and infectious diseases. One of its primary goals is to enable patients around the world to access more accurate diagnostics and to ensure physicians have the diagnostic tools and data they need to make better therapy recommendations to patients. Its rich research and development division combines cutting-edge technologies such as next-generation sequencing, miRNA, and epigenetics, alongside AI-based analytical tools. The company's strong and diverse partnerships help deliver affordable precision medicine that will improve patients' care and quality of life. AID Genomics is a member of the AID Private Equity Group.
What sector is AID Genomics in?
AID Genomics operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, with core technologies in Biologicals, Genes, Artificial Intelligence. Target customers: Healthcare & Life Sciences, Healthcare, Patients.
Where is AID Genomics located?
AID Genomics is based in Prof. Menahem Plaut Street 10, Rehovot, Israel, Center District. The company also has offices abroad.